Bladder cancer clinical trials study investigational medications alone, or in combination with other study medications, or standard of care therapy.

The most common type of bladder cancer is urothelial carcinoma. This type of cancer begins when cells inside the urinary bladder start to grow rapidly. As more cancer cells build up, they form a tumor, which can grow through the layers of the bladder and spread to other areas of the body. When the cancer has not grown into the muscle layer of the bladder it is called non-muscle invasive bladder cancer.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Resources for patients

For help understanding clinical trial listings and for other resources, visit our Patient Resources section.
Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.
Learn more
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.